Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zuberitamab plus Bendamustine in treatment-naïve follicular lymphoma
NCT06757894Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2025
- Primary completion
- Feb 2028
- Modality
- IgG Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of hlx01 in follicular lymphoma (FL), sponsored by Sun Yat-sen University. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
hlx01
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT06757894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06757894.